Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.65% dropped 0.05% to $163.78 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -2.27% rising 0.37% to 4,536.19 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -2.53% rising 0.43% to 35,609.34. Johnson & Johnson closed $16.14 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -1.29% fell 1.68% to $378.54, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -3.79% rose 1.99% to $81.07, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +6.11% rose 1.69% to $42.80. Trading volume (6.0 M) remained 76,137 below its 50-day average volume of 6.0 M.